TAp73 is a marker of glutamine addiction in medulloblastoma. (2017)

First Author: Niklison-Chirou MV
Attributed to:  A BMI1/CHD7 signature in medulloblastoma with poor prognosis. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/gad.302349.117

PubMed Identifier: 28971956

Publication URI: http://europepmc.org/abstract/MED/28971956

Type: Journal Article/Review

Volume: 31

Parent Publication: Genes & development

Issue: 17

ISSN: 0890-9369